U.S. markets closed
  • S&P 500

    4,288.05
    -11.65 (-0.27%)
     
  • Dow 30

    33,507.50
    -158.84 (-0.47%)
     
  • Nasdaq

    13,219.32
    +18.05 (+0.14%)
     
  • Russell 2000

    1,785.10
    -9.21 (-0.51%)
     
  • Crude Oil

    90.77
    -0.94 (-1.02%)
     
  • Gold

    1,864.60
    -14.00 (-0.75%)
     
  • Silver

    22.39
    -0.35 (-1.54%)
     
  • EUR/USD

    1.0575
    +0.0008 (+0.07%)
     
  • 10-Yr Bond

    4.5730
    -0.0240 (-0.52%)
     
  • GBP/USD

    1.2201
    -0.0005 (-0.04%)
     
  • USD/JPY

    149.3300
    +0.0560 (+0.04%)
     
  • Bitcoin USD

    27,028.79
    +168.86 (+0.63%)
     
  • CMC Crypto 200

    579.66
    +0.90 (+0.15%)
     
  • FTSE 100

    7,608.08
    +6.23 (+0.08%)
     
  • Nikkei 225

    31,857.62
    -14.90 (-0.05%)
     

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?

The number of people with COVID-19 has been rising rapidly in China in recent weeks, and there are concerns that the government in Beijing could consider reviving its strict lockdown policies again. COVID-19 cases have been surging in China, largely due to the spread of the omicron XBB variants. In February, the Centers for Disease Control and Prevention pointed to early study results showing that for the bivalent vaccine boosters created to target omicron variants, "[vaccine effectiveness] was generally similar against BA.5-related infections [original omicron] and XBB/XBB.1.5-related infections."